PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
17-May-2022 Avillion announces publication of positive full results from MANDALA Phase III trial of AstraZeneca’s PT027 in asthma patients in the New England Journal of Medicine Avillion
17-May-2022 Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy Sanofi
12-May-2022 This move is important to you. To support you to get that job, PharmiWeb.Jobs are delighted to announce they’ve partnered with CareerJay CareerJay, PharmiWeb
12-May-2022 Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials Novotech Health Holdings Pte Ltd
11-May-2022 Vagarights to Investigate the Use of Natural Stimulants to Treat ADHD VAGARIGHTS
11-May-2022 Evaluate appoints Matthew Wright as Chief Financial Officer RealWire
10-May-2022 Paradigm4 launches REVEAL: Proteomics to transform protein bio-marker research Paradigm4
10-May-2022 UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis UCB
09-May-2022 Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey mdgroup
06-May-2022 Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction AstraZeneca
05-May-2022 New EFSA opinion offers future FSMP application potential for Bimuno® prebiotic ingredient Clasado Biosciences
05-May-2022 Novotech Acquires US CRO NCGS, Expands Global Expertise Novotech Health Holdings Pte Ltd
04-May-2022 Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger Phesi
03-May-2022 BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY II Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer’s Disease BioXcel Therapeutics
03-May-2022 JYSELECA®▼ (filgotinib), recommended by the Health Service Executive (HSE) for people with Ulcerative Colitis (UC) in Ireland Galapagos Biotech LTD
28-Apr-2022 AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem AARDEX® Group
26-Apr-2022 Priothera Receives FDA clearance of Investigational New Drug (IND) to start Phase 2b/3 study with mocravimod in Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Priothera
25-Apr-2022 Mundipharma and Cidara Therapeutics Announce First Presentation of Results from Global Phase 3 ReSTORE Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrating its Positive Efficacy and Safety Profile Mundipharma and Cidara
21-Apr-2022 Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe Panthera Biopartners
20-Apr-2022 ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy ProQR Therapeutics N.V.